The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

Clinical trial NCT05596981 · UNKNOWN

Trial details

NCT number: NCT05596981
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Myeloid Leukemia With FLT3/ITD Mutation Allogeneic Hematopoietic Stem Cell Transplantation

Start date: 2022-10-01
Primary completion: 2023-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.